Indaptus Therapeutics
INDP
15 hedge funds and large institutions have $1.31M invested in Indaptus Therapeutics in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
0% more funds holding
Funds holding: 15 → 15 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
0.52% less ownership
Funds ownership: 0.74% → 0.22% (-0.52%)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
81% less capital invested
Capital invested by funds: $6.81M → $1.31M (-$5.51M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$54.7K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.2K |
| 3 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
+$8.04K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.76K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$78 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
-$3.24M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$169K |
| 3 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
-$60K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$13K |
| 5 |
Morgan Stanley
New York
|
-$78 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $645K | +$13.2K | +169 | +2% |
|
|
IHL
2
Investment House LLC
Redondo Beach,
California
| $250K | – | – | – |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $136K | -$169K | -2,163 | -54% |
|
|
SWP
4
Stratos Wealth Partners
Beachwood,
Ohio
| $70K | -$3.24M | -41,483 | -98% |
|
|
VCM
5
Vivaldi Capital Management
Chicago,
Illinois
| $63K | – | – | – |
|
6
State Street
Boston,
Massachusetts
| $51K | – | – | – |
|
|
7
Renaissance Technologies
New York
| $51K | +$54.7K | +700 | New |
|
8
Northern Trust
Chicago,
Illinois
| $27K | – | – | – |
|
|
HIIFS
9
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
| $7K | +$8.04K | +103 | New |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $4K | +$4.76K | +61 | New |
|
|
11
Morgan Stanley
New York
| $1K | -$78 | -1 | -5% |
|
12
National Bank of Canada
Montreal,
Quebec, Canada
| $1K | – | – | – |
|
|
UCFA
13
United Capital Financial Advisors
Irving,
Texas
| – | -$60K | -536 | Closed |
|
|
14
UBS Group
Zurich,
Switzerland
| – | -$13K | -118 | Closed |
|
|
15
Osaic Holdings
Scottsdale,
Arizona
| – | +$78 | +1 | New |
|
INDP Hedge Fund Activity: Q2 2022 in Review
15 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Indaptus Therapeutics (INDP) for Q2 2022, worth a combined $1.31M — down 81% from $6.81M a quarter earlier.
Fund positioning in INDP was balanced in Q2 2022: 4 funds opened new positions, 4 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $54.7K. The largest seller was Stratos Wealth Partners, cutting an estimated $3.24M.
- 15 institutional investors held Indaptus Therapeutics (INDP) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $1.31M of Indaptus Therapeutics stock for Q2 2022, down 81% quarter-over-quarter.
- 4 funds opened new Indaptus Therapeutics positions in Q2 2022 and 4 closed out, a net change of 0 holders.
- The largest Indaptus Therapeutics buyer in Q2 2022 was Renaissance Technologies, an estimated $54.7K added.
- The largest Indaptus Therapeutics seller in Q2 2022 was Stratos Wealth Partners, an estimated $3.24M sold.
Based on aggregated 13F filings for Q2 2022.